How many insider declarations has Glover Stephen C. filed?

Glover Stephen C. has filed 3 public insider declarations with SEC (Form 4).

What is Glover Stephen C.'s role?

Glover Stephen C.'s reported role is not specified by the regulator across the filings.

Which companies does Glover Stephen C. report trades for?

Glover Stephen C. reports trades for 3 companies, including PDS Biotechnology Corp.

What is Glover Stephen C.'s declared buy vs sell volume?

Across the available history, declared buys total 24k€ and disposals 0.

← Executives ★ Sign in to follow

GS

Glover Stephen C.

·SEC (Form 4)

PDS Biotechnology Corp ZyVersa Therapeutics, Inc.Ambrx Biopharma Inc.

0

申报总数

0

公司

€24,051

▲ 买入（1 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

1

已披露卖出

0

T+90 胜率

100%

T+90 平均收益

+11.8%

基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。

信号历史

无可用的信号评分。

Browse the complete record of transactions filed by Glover Stephen C.. Insider active across 3 companies, notably PDS Biotechnology Corp. Cumulatively, 3 disclosures have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €24k. History available since 7 June 2023. The latest transaction was filed on 28 February 2025 (Acquisition). Regulator: SEC (Form 4). All data is openly available.

Companies and markets linked to Glover Stephen C.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

PDS Biotechnology Corp (US)ZyVersa Therapeutics, Inc. (US)Ambrx Biopharma Inc. (US)

申报3 总计

▲

Glover Stephen C.

Director高管2025年2月28日PDS Biotechnology Corp

US$25,00135SEC ↗

15,061 股@ US$1.66100.0% 占其流量Common StockSEC:0001140361-25-006783:0

标准退出：2025年5月29日 (T+90)

◆

Glover Stephen C.

Director高管2023年6月7日Ambrx Biopharma Inc.

0SEC ↗

85,000 股0Ordinary SharesSEC:0000899243-23-015185:0

◆

Glover Stephen C.

Chief Executive Officer高管2022年12月12日ZyVersa Therapeutics, Inc.

0SEC ↗

448,909 股Common StockSEC:0001493152-22-035479:0

3 条申报中的 3 条

InsidersTradesSigma

← Executives ★ Sign in to follow

GS

Glover Stephen C.

·SEC (Form 4)

PDS Biotechnology Corp ZyVersa Therapeutics, Inc.Ambrx Biopharma Inc.

0

申报总数

0

公司

€24,051

▲ 买入（1 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

1

已披露卖出

0

T+90 胜率

100%

T+90 平均收益

+11.8%

基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。

信号历史

无可用的信号评分。

Browse the complete record of transactions filed by Glover Stephen C.. Insider active across 3 companies, notably PDS Biotechnology Corp. Cumulatively, 3 disclosures have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €24k. History available since 7 June 2023. The latest transaction was filed on 28 February 2025 (Acquisition). Regulator: SEC (Form 4). All data is openly available.